|Articles|April 1, 2013
- Pharmaceutical Executive-04-01-2013
- Volume 0
- Issue 0
PE, April 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
almost 13 years ago
Country Report: Belgiumalmost 13 years ago
On-Market Pricing Strategiesalmost 13 years ago
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?almost 13 years ago
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumphalmost 13 years ago
Pfizer's Quality by Design Approach to Trial Managementalmost 13 years ago
Woman of the Year 2013almost 13 years ago
Key to Brand Positioning: Look Inside Your Heartalmost 13 years ago
Full Disclosure for PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
FDA Expands Approval for Arexvy for Adult Patients Aged 18-49
4
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
5